학술논문

A novel virtual reality‐based theory of mind intervention for outpatients with schizophrenia: A proof‐of‐concept pilot study.
Document Type
Article
Source
Clinical Psychology & Psychotherapy. May2021, Vol. 28 Issue 3, p727-738. 12p. 2 Color Photographs, 1 Diagram, 3 Charts, 2 Graphs.
Subject
*SCHIZOPHRENIA treatment
*THOUGHT & thinking
*PILOT projects
*VIRTUAL reality
*FUNCTIONAL status
*INDIVIDUALIZED medicine
*COGNITION
*LANGUAGE & languages
*TREATMENT effectiveness
*RANDOMIZED controlled trials
*BEHAVIOR disorders
*COMPARATIVE studies
*QUALITY of life
*ANALYSIS of covariance
*STATISTICAL sampling
*COGNITIVE therapy
*EVALUATION
Language
ISSN
1063-3995
Abstract
Schizophrenia is a severe and highly disabling mental illness. Although several pharmacological solutions are available to alleviate symptoms of schizophrenia, they do not seem to provide solution for accompanying social dysfunctions. To handle this unmet clinical need, many innovative interventions have been developed recently. Considering the promising results on this field and the development trend, characterized by the growing proportion of included interactive technology, our research team developed a novel virtual reality (VR)‐based targeted theory of mind (ToM) intervention (VR‐ToMIS) for stable outpatients with schizophrenia. VR‐ToMIS is a nine‐session long structured and individualized method that uses cognitive and behavioural therapeutic techniques in an immersive VR environment. Our study was a randomized, controlled pilot study. Twenty‐one patients have been recruited and randomly allocated to either VR‐ToMIS or passive VR condition. Patients assigned to passive VR condition could use the same VR software as the VR‐ToMIS group, but without any interventions. Effects on psychiatric symptoms, neurocognitive and social cognitive functions, pragmatic language skills and quality of life were evaluated by using analysis of covariance. According to our results, VR‐ToMIS was associated with improvements in negative symptoms, in one neurocognitive field (immediate memory), ToM and pragmatic language skills, but no significant change in quality of life scores was detected. Significant changes in VR‐ToMIS group were associated with moderate to large therapeutic effects (ηp2 =.24–.46, φ =.55–.67). On the background of the presented pilot results, VR‐ToMIS is concluded to be feasible and tolerable. [ABSTRACT FROM AUTHOR]